Guidant Shows RESOLVE In Quest For Elusive AF Ablation Indication
This article was originally published in The Gray Sheet
Executive Summary
Guidant will submit data from its RESOLVE-AF trial to FDA in 2007 to support an atrial fibrillation indication for its Flex microwave ablation catheter
You may also be interested in...
FDA Should Design AF Trials To Remove Sponsor Guesswork – HRS’ Calkins
The Heart Rhythm Society should work with FDA to develop detailed sample trial designs for atrial fibrillation ablation devices, according to Hugh Calkins, HRS trustee and director of electrophysiology at Johns Hopkins University
Cardima Seeks Suitor For Its Surgical Ablation Catheter Business By June
Cardima aims to find an acquirer for the Revelation Tx ablation catheter and all other assets by the end of Q2 to avoid conducting another financing round
Guidant Enters Surgical Ablation Field Via AFx Purchase, Seeks AF Indication
AFx, Inc.'s microwave ablation technology is more suitable for minimally invasive atrial fibrillation (AF) procedures than competing radio frequency systems, Guidant claims